Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_2023_Sopharma_Rus_espi.pdf Optimization of the activity in foreign markets

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 192 / 2023
Date of issue: 2023-10-16
Short name of the issuer
SOPHARMA AD
Subject
Optimization of the activity in foreign markets
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) notifies that in fulfillment of the goals for optimization of the foreign markets activities, the functions of the representative office of "Sopharma" AD in Russia will be taken over by the newly established subsidiary "Sopharma Rus" EOOD.
Annexes
File Description
SFA_2023_Sopharma_Rus_espi.pdf
SFA_2023_Sopharma_Rus_espi.pdf		 Optimization of the activity in foreign markets

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-10-16 Ognian Donev Executive Director
20231016_140853_1645933271_SFA_2023_Sopharma_Rus_espi.pdf

Pobierz